Ankur Mittal is a dedicated biomedical researcher specializing in molecular biology, microbiology, and clinical biochemistry, currently engaged in basic research on infectious and metabolic diseases. His work focuses on developing rapid molecular diagnostic platforms for Fungal Endophthalmitis and employing metagenomic sequencing for advanced microbial characterization. His research aims to integrate molecular diagnostics with clinical applications to enhance early disease detection and therapeutic outcomes.
He previously contributed to significant projects exploring Diabetic Retinopathy (DR) and Age-Related Macular Degeneration (AMD), particularly investigating the role and balance of VEGF165 and VEGF165b proteins in pathological angiogenesis. His work elucidated mechanisms underlying impaired protein expression in retinal disorders, contributing to a deeper understanding of molecular processes in ocular pathology.
Mr. Mittal completed his Master of Science (M.Sc.) in Biochemistry from the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh (2014–2016), where he specialized in cell and molecular biology, immunogenetics, bioinformatics, and gene-based diagnostics. He earned his Bachelor of Science (B.Sc.) in Microbiology from Delhi University (2010–2013), graduating with a strong foundation in medical, industrial, and molecular microbiology.
His research contributions are documented through publications in reputed journals, including Kidney Diseases (2018), International Journal of Drug Development & Research (2016), and Pharmacology Research (2016). Additionally, he has presented his work at several national scientific conferences, such as ACBICON 2015 and the National Conference on Frontiers in Applied Biotechnology, and has participated in numerous workshops on flow cytometry, big data science, immunology, and biotechnology at leading institutions such as INSA, ILBS, and TERI University.